gene therapy - search results

In this exclusive interview with Prof Olufunmilayo Lesi, Regional Medical Officer for Viral Hepatitis from the World Health Organization (WHO) Office for the Africa Region, discusses tackling viral hepatitis in Africa.

In this detailed analysis, Jérôme Galon and Daniela Bruni at INSERM, Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, in France, discuss colorectal cancer.

Steve Jones, Chair Action for Pulmonary Fibrosis and Board Member EU-IPFF and Gisli Jenkins from Nottingham University Hospitals, explain idiopathic pulmonary fibrosis (IPF), an incurable lung disease.

Here, the tangible impact on diabetes patients and their care is thoroughly explored via integrated personalised diabetes management (iPDM).

Using cross-disciplinary technology, Dr Kunio Matsumoto, PhD, Professor at Kanazawa University in Japan is extending research on growth factor toward synthetic biologics for regeneration-based medicine and cancer theranostics.

Christoph Brochhausen, Max Babel, Tanja Neumair, Karl Friedrich Becker, Judita Kinkorova, Ondrej Topolcan, explain here exactly how BRoTHER brings biobank know-how to scientists, students and the public.

GreenLight Medicines is a supplier of quality supplements and is an active MedCan research company GreenLight, Supplements and Medicines.

Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the WHO Region of Africa.

Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.

Here, Laser Ablation in Liquid (LAL) is explored as means to understand the shapes and sizes of nanoparticles.

Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.

Professors Darren K Griffin and Alan R Thornhill discuss their research on exploring a person’s genome sequencing.

A new £2.6 million project led by Swansea University Medical School aims to dramatically improve the diagnosis and treatment of ovarian cancer.

Dr Elizabeth Robertson, Director of Research at Diabetes UK explains why 2019 marked turning a corner in the prevention of Type 1 diabetes but adds that there is still more research to be done in this area.

John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.

Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.

Nick Bennett, CEO at Fika, puts forward the case for a positive and preventative approach to mental health for university students, drawing on learnings from physical fitness and positive psychology.

Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.

Katharine Moore Tibbetts, Assistant Professor at Virginia Commonwealth University, shares with us her expertise on advances in engineering functional nanomaterials, an area of chemistry research that has benefitted society in various ways.

The European Red Cell Society’s met the partners of the EU intellectual training network RELEVANCE at Mount of Truth in Ascona, Switzerland to discuss the latest progress.